miRecule
  • Home
  • Technology Platform
  • Programs
  • Team
  • News
  • Join Us
  • Contact
Select Page

miRecule and UMB awarded Maryland Industrial Partnerships Grant for translational FSHD research!

by Ashwin Kulkarni | Feb 28, 2022 | Announcement

Collaboration will focus on development of translational biomarkers for FSHD – mirecule.com

miRecule brings on Janssen vet Fu-An Kang to lead expanding research team!

by Ashwin Kulkarni | Jun 8, 2021 | Announcement

Accomplished drug hunter will oversee the discovery and development of miRecule’s leading RNA therapies – miRecule.com

miRecule Inc. closes $5.7M to create breakthrough RNA therapies for cancer & muscular dystrophy!

by Ashwin Kulkarni | May 27, 2021 | Announcement

Read the full story here: Global News Wire

miRecule published in Clinical Cancer Research!

by Ashwin Kulkarni | Dec 16, 2020 | Uncategorized

Integrated genomic and functional microRNA analysis identifies miR-30-5p as a tumor suppressor and potential therapeutic nanomedicine in head and neck cancer – Clinical Cancer Research

miRecule featured by the BioHealth Capital Region Investment Conference!

by Ashwin Kulkarni | Dec 16, 2020 | Uncategorized

miRecule closes Seed Round at the second annual BioHealth Capital Region Investment Conference  – BioBuzz
« Older Entries

miRecule, Inc.
704 Quince Orchard Road
Gaithersburg, MD 20878

  • Follow
  • Follow